The impact of repeated rounds of mass drug administration with diethylcarbamazine plus albendazole on bancroftian filariasis in Papua New Guinea.
<h4>Background</h4>This study employed various monitoring methods to assess the impact of repeated rounds of mass drug administration (MDA) on bancroftian filariasis in Papua New Guinea, which has the largest filariasis problem in the Pacific region.<h4>Methodology/principal findin...
Main Authors: | Gary J Weil, Will Kastens, Melinda Susapu, Sandra J Laney, Steven A Williams, Christopher L King, James W Kazura, Moses J Bockarie |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2008-01-01
|
Series: | PLoS Neglected Tropical Diseases |
Online Access: | https://journals.plos.org/plosntds/article/file?id=10.1371/journal.pntd.0000344&type=printable |
Similar Items
-
Pharmacokinetics of Moxidectin combined with Albendazole or Albendazole plus Diethylcarbamazine for Bancroftian Filariasis.
by: Yashpal S Chhonker, et al.
Published: (2023-08-01) -
Alternative approaches for monitoring and evaluation of lymphatic filariasis following mass drug treatment with ivermectin, diethylcarbamazine and albendazole in East New Britain Province, Papua New Guinea.
by: Krufinta Bun, et al.
Published: (2025-01-01) -
Impact of mass drug administration with ivermectin, diethylcarbamazine, and albendazole for lymphatic filariasis on hookworm and Strongyloides stercoralis infections in Papua New Guinea.
by: Jannet A Tobon Ramos, et al.
Published: (2025-03-01) -
An open label, randomized clinical trial to compare the tolerability and efficacy of ivermectin plus diethylcarbamazine and albendazole vs. diethylcarbamazine plus albendazole for treatment of brugian filariasis in Indonesia.
by: Taniawati Supali, et al.
Published: (2021-03-01) -
Potential Value of Triple Drug Therapy with Ivermectin, Diethylcarbamazine, and Albendazole (IDA) to Accelerate Elimination of Lymphatic Filariasis and Onchocerciasis in Africa.
by: Peter U Fischer, et al.
Published: (2017-01-01)